Microbio is thrilled to celebrate its five-year anniversary today (Thursday, 21 July 2022). This day marks five years of hard work and determination by the talented, growing team making positive contributions to the health of people everywhere.
Microbio has gone from strength to strength in its first five years.
Recent international achievements include the clearance to sell Microbio’s flagship test, InfectID-BSI, in Europe. This closely followed the company’s debut at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal where Microbio representatives presented posters.
Closer to home, Microbio moved into new headquarters at Brisbane’s Translational Research Institute (TRI) in 2021. This move coincided with Microbio shifting its focus from discovery to application of its InfectID suite of tests in the community. The TRI facilities will also help to set up domestic manufacturing capabilities.
Staff numbers have grown with the company, from the two founders to a diverse, high-performing team of 14 full- and part-time employees. An increasing number of overseas consultants and advisers are joining the exceptional team.
As Microbio continues to achieve national and international recognition, the company has 0benefitted from the services of internationally based consultants and attracted a number of
high-profile shareholders. The scale-up recently restructured to an unlisted public company, backed by more than 50 shareholders.
The company’s success to date would not have been possible without the incredible talent and dedication of Microbio’s passionate staff. Thank you to all staff that have been a part of this journey during the last five years.
Microbio is proud of what it has accomplished and looks forward to many more years of research and innovation to improve health and wellbeing around the world.